Reply to: “UKALL 2011: Flawed Noninferiority and Overlooked Interactions Undermine Conclusions” and “Understanding the Potential Importance of Pharmacokinetic Variability in the Setting of ALL”
Authors:
- 1 October 2025
- journal article
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 43 (28) , 3138-3139
Abstract
No abstract availableThis publication has 9 references indexed in Scilit:
- UKALL 2011: Flawed Noninferiority and Overlooked Interactions Undermine ConclusionsJournal of Clinical Oncology, 2025
- Understanding the Potential Importance of Pharmacokinetic Variability in the Setting of ALLJournal of Clinical Oncology, 2025
- High-Dose Methotrexate in Children and Young Adults With ALL and Lymphoblastic Lymphoma: Results of the Randomized Phase III Study UKALL 2011Journal of Clinical Oncology, 2025
- Pulse therapy with vincristine and dexamethasone for childhood acute lymphoblastic leukaemia (CCCG-ALL-2015): an open-label, multicentre, randomised, phase 3, non-inferiority trialThe Lancet Oncology, 2021
- Total Body Irradiation or Chemotherapy Conditioning in Childhood ALL: A Multinational, Randomized, Noninferiority Phase III StudyJournal of Clinical Oncology, 2021
- Children’s Oncology Group AALL0434: A Phase III Randomized Clinical Trial Testing Nelarabine in Newly Diagnosed T-Cell Acute Lymphoblastic LeukemiaJournal of Clinical Oncology, 2020
- Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trialEuropean Journal of Cancer, 2019
- Dexamethasone and High-Dose Methotrexate Improve Outcome for Children and Young Adults With High-Risk B-Acute Lymphoblastic Leukemia: A Report From Children’s Oncology Group Study AALL0232Journal of Clinical Oncology, 2016
- Risk-adjusted therapy of acute lymphoblastic leukemia can decrease treatment burden and improve survival: treatment results of 2169 unselected pediatric and adolescent patients enrolled in the trial ALL-BFM 95Blood, 2008